Skip to main content
Log in

Anti-Sm faces a threat to its reigning position as the marker antibody

  • Letter to the Editor
  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Al-Jabri AA, Al-Gahdani AK, Al-Shualli I (2009) High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus. Rheumatol Int 30:51–56

    Article  PubMed  CAS  Google Scholar 

  2. Al-Maini MH, El-Ageb EM, Al-Wahaibi SS, Al-Farsi Y, Richens ER (2003) Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in Oman. Rheumatol Int 23:186–191

    Article  PubMed  CAS  Google Scholar 

  3. Tan EM, Kunkel HG (1966) Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 96:464–471

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Think-You Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jearn, LH., Kim, TY. Anti-Sm faces a threat to its reigning position as the marker antibody. Rheumatol Int 31, 1119–1120 (2011). https://doi.org/10.1007/s00296-010-1537-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-010-1537-8

Keywords

Navigation